<DOC>
	<DOCNO>NCT00616304</DOCNO>
	<brief_summary>Background : Mortality severe malaria remain ~15 % despite use rapidly parasiticidal antimalarial therapy , artesunate . Adjunctive treatment may improve outcome . Our overall goal determine adjunctive treatment L-arginine safe improves outcomes severe malaria . In study date , show L-arginine safe moderately severe malaria , increase nitric oxide production improve endothelial function . We propose extend study patient severe malaria . Aims : To determine safety , preliminary efficacy , pharmacokinetics pharmacodynamics L-arginine infusion severe malaria . Hypothesis : L-arginine improve endothelial function , lactate clearance time tissue oxygen delivery compare saline clinically significant adverse effect . Methods : Based previous pharmacokinetic modeling simulation , propose phase 2A randomise control trial L-arginine v saline severe malaria , give 8 hour . If safety demonstrate follow phase 2B open-label study 24-hour infusion L-arginine severe malaria safety preliminary efficacy compare 8 hour infusion give phase 2A . The primary outcome improvement endothelial function lactate clearance patient give L-arginine infusion compare receive saline . Among secondary outcome safety effect L-arginine v saline tissue oxygen delivery ( NIRS ) . Data phase 2A 2B used generate pharmacokinetic/ pharmacodynamic model .</brief_summary>
	<brief_title>Safety Preliminary Efficacy L-arginine Severe Falciparum Malaria</brief_title>
	<detailed_description>See brief summary</detailed_description>
	<mesh_term>Malaria</mesh_term>
	<mesh_term>Malaria , Falciparum</mesh_term>
	<criteria>1. age 1860 year 2. informed consent obtain 3. time commencement artesunate â‰¤18 hr infusion Larginine 4. level P. falciparum parasitemia , one follow criterion : i. acute renal failure ( creatinine &gt; 265umol/L ) ii . hyperbilirubinemia ( total bilirubin &gt; 50 umol/L ) either renal impairment ( creatinine &gt; 130umol/L ) parasitemia &gt; 100,000 parasites/uL iii . blackwater fever iv . hyperparasitemia ( &gt; 10 % parasitised red cell ) v. cerebral malaria ( Glasgow coma score &lt; 11 ) vi . Hypoglycemia vii . Respiratory distress ( RR &gt; 32 ) 1. pregnancy lactation 2. diabetes 3. serious preexist disease ( cardiac , hepatic , kidney ) 4. systolic blood pressure &lt; 90 mmHg fluid resuscitation 5. initial iSTAT test show follow value : i. K+ &gt; 5.5 meq/L ii . Cl &gt; 110 meq/L iii . HCO3 &lt; 15 meq/L 6. know allergy Larginine 7. evidence concurrent bacterial infection 8. concurrent therapy follow medication : iv . spironolactone , v. oral nitrate , vi . phosphodiesterase inhibitor ( eg sildenafil [ Viagra ] ) vii . alphablocking antihypertensive agent ( eg prazosin ) viii . Larginine</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>severe falciparum malaria</keyword>
</DOC>